期刊文献+

一例重症/难治性哮喘合并肺栓塞的机制探究和体会 被引量:2

Exploration and experience of one case of severe/refractory asthma complicated with pulmonary embolism
原文传递
导出
摘要 目的通过病例报道及文献回顾探讨重症/难治性哮喘合并肺栓塞的可能机制,并提供经验和更全面的认识。方法报道中日友好医院收治的1例重症/难治性哮喘合并肺栓塞患者,并对已发表的重症/难治性哮喘合并肺栓塞国内外文献进行归纳总结。结果国内关于哮喘合并肺栓塞的文献报道不多见,但是国外文献研究显示,其发病率并不低,临床医师在临床工作中应重视哮喘合并肺栓塞的病例。结论哮喘患者需经常使用皮质激素治疗,重症/难治性哮喘则需长期口服皮质激素控制,加上低氧、气道炎症刺激均为血栓形成的高危因素,此为重症/难治性哮喘合并肺栓塞的可能机制。 Objective To explore the mechanism and provide more comprehensive understanding of severe/refractory asthma complicated with pulmonary embolism through case reports and literature review. Methods A patient with severe/refractory asthma complicated with pulmonary embolism admitted to China-Japan Friendship Hospital was reported, and the related literatures published at home and abroad were summarized. Results Domestic literatures on asthma complicated with pulmonary embolism were rare, but foreign studies had shown that its incidence was not low.The clinicians should pay more attention to asthma complicated with pulmonary embolism. Conclusions Patients with asthma are often treated with corticosteroids.In addition, patients with severe/refractory asthma require long-term oral corticosteroid control.Hypoxia and airway inflammation are high risk factors for thrombosis.These may be the possible mechanisms for severe/refractory asthma complicated with pulmonary embolism.
作者 卢朝晓 苏楠 崔晓阳 王辰 Lu Chaoxiao;Su Nan;Cui Xiaoyang;Wang Chen(Department of Respiratory and Critical Care Medicine, Center for Respiratory Diseases, China- Japan Friendship Hospital, National Clinical Research Center for Respiratory Diseases, Beijing 100029, China;Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730;Department of Respiratory and Infection Medicine, Tianshui 407 Hospital, Tianshui 741000, China)
出处 《国际呼吸杂志》 2019年第13期995-998,共4页 International Journal of Respiration
基金 国家重点研发计划(2016YFC0901103).
关键词 哮喘 肺栓塞 机制 Asthma Pulmonary embolism Mechanism
  • 相关文献

参考文献4

二级参考文献57

  • 1国家"十五"攻关"肺栓塞规范化诊治方法的研究"课题组,杨媛华,翟振国,武燕兵,王辰.急性肺血栓栓塞症患者516例临床表现分析[J].中华医学杂志,2006,86(31):2161-2165. 被引量:78
  • 2陆芸,马宝通,郭若霖,张建国,吴英华,庞贵根,辛景义,叶伟胜,邹玉安,王毅,董强,王学谦,Kerry H,Paul C,John F.骨科创伤患者深静脉血栓危险因素的研究[J].中华骨科杂志,2007,27(9):693-698. 被引量:244
  • 3GINA report, global strategy for asthma management and preven- tion. www.ginasthma.com, 2010. Accessed February 25, 2012.
  • 4Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Issued 1995 (NIH pub no. 02-3659); Accessed December 2011.
  • 5Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. ] Allergy Clin lmmunol, 2003, 111 (2): $486-494.
  • 6Chanez P, Contin-Bordes Cc, Garcia G, et al. Omalizumab-induced decrease of FceRI expression in patients with severe allergic asthma. RespirMed, 2010, 104(11): 1608-1617.
  • 7Higgins JPT, Green S (editors). Cochrane Handbook for System-atic Reviews of Interventions Version 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011.
  • 8Available from: http://www. cochrane-handbook.org.
  • 9Soler M, Matz J, Townley R, et al. The anti-IgE antibody omali- zumab reduces exacerbations and steroid requirement in allergic asthmatics. Official Journal of the European Society for Clinical Res- piratory Physiology, 2001, 18(2): 254-261.
  • 10Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recom- binant humanized monoclonal antibody, for the treatment of severe allergic asthma. The Journal of Allergy and Clinical Immunology, 2001, 108(2): 184-190.

共引文献1118

同被引文献16

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部